July 27, 2006
IVIG Supply Index represents FFF's aggregate inventory of all IVIG products for our customers who have established product allocations with us. Red represents 21 days supply or less, yellow is 22 to 29 days, green is 30 days supply or more.
From the House Ways and Means Committee
Subcommittee on Health, Hearing on Medicare Reimbursement of Physician-Administered Drugs
LINK...

From Novartis
Novartis to Build Latest-Technology Influenza Vaccines Manufacturing Site in North Carolina
LINK...

From Health and Human Services
HHS Assists States With Another Antiviral Drug Purchase  LINK...

From the Business Standard
Bird Flu Vaccine Mass Production Begins  LINK...

From the FDA
FDA Names First Medical Director for Emerging and Pandemic Threat Preparedness in the Center for Biologics Evaluation and Research  LINK...

From the RFID Journal
Congress Subcommittee Holds Hearing on Halting Drug Counterfeiting   LINK...

FFF Introduces Online Immune Globulin Therapy Tracking System

FFF Enterprises' specialty pharmacy services company has recently launched our Immune Globulin Treatment Tracker (IGTT), an online system that tracks, monitors and reports individual patient immune globulin therapy.

Patients can use IGTT to:

  • Log onto a private web page to easily record immune globulin treatments.
  • Create an electronic record of healthcare in one location.
  • Document exact IG administration sites on a body image for any infusion method: IVIG, SCIG and port.
  • Record the amount and rate of IG treatments — and any changes.
  • Track infusion attempts and reactions.
  • Record lab and test results, and look them up quickly and easily.
  • Print reports to share with physicians, improving communications and making appointments more productive.
  • Securely store and retrieve information whenever it is needed.
The system improves communications between patients and physicians by allowing a comprehensive view of the patient's immune globulin treatment and related health issues between visits.

"We are pleased to be able to provide IG Treatment Tracker as a complimentary service to our immune globulin patients," said Patrick M. Schmidt, FFF's president and CEO. "The freedom and control the system offers to help healthcare consumers is empowering."





Red represents 21 days supply or less, yellow is 22 to 29 days, green is 30 days supply or more.






FFF Enterprises Granted Verified-Accredited Wholesale Distributors Accreditation by the National Association of Boards of Pharmacy
FFF Enterprises is pleased to announce that we have been awarded Verified-Accredited Wholesale Distributors (VAWD) accreditation by the National Association of Boards of Pharmacy (NABP). The VAWD program was developed to help protect the public from the threat of counterfeit drugs to the United States' drug supply.

FFF is one of only six wholesale distributors in the nation that have earned NABP accreditation.

"We are very pleased to have received accreditation by the NABP," said Patrick M. Schmidt, FFF Enterprises president and CEO. "This program is fully supported by the FDA and, along with our Guaranteed Channel Integrity, it is one more way to assure our patients that the products we distribute are being handled with the utmost safety and care."

FFF is also able to verify the security of our supply channel with our Verified Electronic Pedigree™ system, or VEP. VEP allows our customers to quickly access a drug pedigree for each product received from FFF.

"Our Verified Electronic Pedigree validates our Guaranteed Channel Integrity," Schmidt explained, "in the same way that the NABP accreditation validates our licensing and good practices. Supply channel and product safety are vital components of quality patient care."

VAWD accreditation provides assurance that FFF operates legitimately, is validly licensed in good standing, and is employing security and best practices for safely distributing prescription drugs from manufacturers to pharmacies and other institutions. Applicants for VAWD undergo a compliance review licensure verification, an inspection, background checks, and screening through NABP's clearinghouse.

BioSupply Trends is published by FFF Enterprises, the nation's most trusted distributor of biopharmaceuticals, plasma products and vaccines. FFF Enterprises is accelerating the availability of products, from development to delivery. Click here to contact FFF Enterprises or call 800-843-7477.

©2006 FFF Enterprises Inc.
Top of Page